Published in
Elsevier, European Urology, 2023
DOI: 10.1016/j.eururo.2022.12.025
Elsevier, European Urology, 3(83), p. 297-298, 2023
DOI: 10.1016/j.eururo.2022.11.010
Links
Tools
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Trial
Journal article published in 2023 by
Zhenjie Wu,
Zine-Eddine Khene,
Linhui Wang,
Savio D. Pandolfo 
,
Delphine Borchiellini,
Riccardo Autorino,
Karim Bensalah
,
Delphine Borchiellini,
Riccardo Autorino,
Karim Bensalah
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 